Robert Dreicer, MD, MS, MACP, FASCO

Robert Dreicer, MD, MS, MACP, FASCO, is the associate director for clinical research and the deputy director of the University of Virginia Comprehensive Cancer Center. He also serves as section mead of medical oncology and co-director of the Paul Mellon Urologic Cancer Institute. He is a professor of medicine and urology at the University of Virginia School of Medicine in Charlottesville. He previously served as chair of the Department of Solid Tumor Oncology at the Cleveland Clinic and deputy associate director for clinical research at the Case Comprehensive Cancer Center. 

Dr Dreicer received his BS degree at Colorado State University and his MS degree at The University of Texas Graduate School of Biomedical Sciences in Houston. He received his MD from The University of Texas Medical School at Houston. He completed an internal medicine residency at Indiana University in Indianapolis, followed by a medical oncology fellowship at the University of Wisconsin Carbone Cancer Center in Madison.

He is board certified in internal medicine and medical oncology. His areas of specialization are in the management of genitourinary malignancies and the design and conduct of clinical trials in urologic oncology. Dr Dreicer has published extensively in genitourinary oncology, and he has served as principal investigator for a large number of studies in genitourinary neoplasms. He served as co-chair of National Cancer Institute Genitourinary Cancers Steering Committee from 2012 to 2018 and is an editorial board member for The New England Journal of Medicine’s Journal Watch Oncology and Hematology. He also currently serves on the American Board of Internal Medicine’s Medical Oncology Longitudinal Assessment Approval Committee. In October 2016, he was awarded Mastership in the American College of Physicians.